Valuation: Dil Ltd

Market Cap 9.39B 98.94M 98.94M 86.58M 79.79M 73.96M 140M 143M 957M 372M 4.63B 371M 363M 16.02B P/E 2024
-18.9x
P/E 2025 10.4x
Enterprise Value 9.83B 104M 104M 90.66M 83.55M 77.44M 147M 149M 1B 390M 4.85B 389M 381M 16.77B EV / Sales 2024
1.54x
EV / Sales 2025 1.81x
Free-Float
25.84%
Yield 2024
0.83%
Yield 2025 0.91%
Manager TitleAgeSince
Chief Executive Officer 56 2021-05-08
Director of Finance/CFO - 2017-02-15
Compliance Officer - 2024-02-11
Director TitleAgeSince
Director/Board Member 56 2022-08-11
Director/Board Member 44 2011-06-21
Director/Board Member 75 2009-12-28
Change 5-day change 1-year change 3-year change Capi.($)
+4.07%+8.45%+25.67%-2.34% 66.11B
-0.24%-3.13%+49.38%+223.97% 55.3B
+1.21%+42.20%+42.20%+42.20% 42.44B
-0.49%+7.54%-50.24%-53.77% 41.28B
-2.48%+13.91%+166.79%-32.89% 32.46B
-1.32%-4.79%+58.07%-25.22% 30.78B
+2.10%+4.14%+75.49%+90.19% 23.1B
+2.12%+11.56%+7.57%+193.55% 20.06B
-0.04%+3.85%+67.76%+135.89% 17.19B
Average +0.52%+4.62%+49.19%+63.51% 36.52B
Weighted average by Cap. +0.76%+4.35%+43.82%+55.55%

Financials

2024 2025
Net sales 3.36B 35.37M 35.37M 30.95M 28.52M 26.44M 50.19M 51M 342M 133M 1.66B 133M 130M 5.73B 4.69B 49.47M 49.47M 43.29M 39.89M 36.98M 70.19M 71.33M 478M 186M 2.32B 186M 182M 8.01B
Net income -231M -2.43M -2.43M -2.13M -1.96M -1.82M -3.45M -3.5M -23.5M -9.14M -114M -9.12M -8.92M -393M 769M 8.1M 8.1M 7.09M 6.53M 6.05M 11.49M 11.68M 78.32M 30.46M 379M 30.4M 29.75M 1.31B
Net Debt 789M 8.32M 8.32M 7.28M 6.71M 6.22M 11.8M 11.99M 80.44M 31.28M 390M 31.23M 30.55M 1.35B 443M 4.67M 4.67M 4.08M 3.76M 3.49M 6.62M 6.73M 45.11M 17.54M 219M 17.51M 17.14M 755M
Logo Dil Ltd
Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. It is also engaged in renting and selling properties. Its segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. It has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and others. It provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, and vitamin AD2 premix, among others.
Employees
-